Seehra Jasbir Insider Trades

Insider Trading History

Track insider trading activity for Seehra Jasbir. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Keros Therapeutics
Keros Therapeutics KROS
CHIEF EXECUTIVE OFFICER
Holding Value $4.63M 440,708 shares
Last Trade
Apr 02, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$660k 55,000 shares
$12.00
$10.50
Keros Therapeutics
Keros Therapeutics KROS
CHIEF EXECUTIVE OFFICER
Holding Value $2.07M 197,444 shares
Last Trade
Apr 02, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$660k 55,000 shares
$12.00
$10.50
Keros Therapeutics
Keros Therapeutics KROS
CHIEF EXECUTIVE OFFICER
Holding Value $2.28M 217,000 shares
Last Trade
Feb 24, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.92M 317,000 shares
$15.52
$10.50
Keros Therapeutics
Keros Therapeutics KROS
CHIEF EXECUTIVE OFFICER
Holding Value $4.05M 385,708 shares
Last Trade
Feb 19, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$113k 7,015 shares
$16.17
$10.50
Keros Therapeutics
Keros Therapeutics KROS
CHIEF EXECUTIVE OFFICER
Holding Value $656k 62,500 shares
Last Trade
Jan 07, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.16M 62,500 shares
$18.56
$10.50
Keros Therapeutics
Keros Therapeutics KROS
CHIEF EXECUTIVE OFFICER
Holding Value $4.12M 392,723 shares
Last Trade
Sep 03, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.43M 90,500 shares
$15.76
$10.50
Keros Therapeutics
Keros Therapeutics KROS
CHIEF EXECUTIVE OFFICER
Holding Value $3.17M 302,223 shares
Last Trade
Apr 04, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$493k 49,367 shares
$9.98
$10.50
Keros Therapeutics
Keros Therapeutics KROS
CHIEF EXECUTIVE OFFICER
Holding Value $2.65M 252,444 shares
Last Trade
Apr 04, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$493k 49,367 shares
$9.98
$10.50
Keros Therapeutics
Keros Therapeutics KROS
CHIEF EXECUTIVE OFFICER
Holding Value $1.31M 125,000 shares
Last Trade
Feb 23, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$7.95M 125,000 shares
$63.61
$10.50
Keros Therapeutics
Keros Therapeutics KROS
CHIEF EXECUTIVE OFFICER
Holding Value $1.31M 125,000 shares
Last Trade
Feb 13, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$7.02M 125,000 shares
$56.18
$10.50
Keros Therapeutics
Keros Therapeutics KROS
Chief Executive Officer
Holding Value $473k 45,087 shares
Last Trade
Apr 08, 2023 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$161k 4,000 shares
$40.14
$10.50
Keros Therapeutics
Keros Therapeutics KROS
Chief Executive Officer
Holding Value $2.65M 252,856 shares
Last Trade
Apr 08, 2023 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$161k 4,000 shares
$40.14
$10.50
Keros Therapeutics
Keros Therapeutics KROS
Chief Executive Officer
Holding Value $2.1M 200,000 shares
Last Trade
Feb 16, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$10.9M 200,000 shares
$54.38
$10.50
Eloxx Pharmaceuticals
Eloxx Pharmaceuticals ELOX
Director
Holding Value $30.2k 20,000 shares
Last Trade
Jun 15, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$204k 20,000 shares
$10.20
$1.51
Keros Therapeutics
Keros Therapeutics KROS
Chief Executive Officer
Holding Value $2.61M 248,856 shares
Last Trade
Jun 09, 2022 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$154k 5,000 shares
$30.84
$10.50
Keros Therapeutics
Keros Therapeutics KROS
Chief Executive Officer
Holding Value $92.6k 8,822 shares
Last Trade
Jun 09, 2022 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$308k 10,000 shares
$30.84
$10.50
Keros Therapeutics
Keros Therapeutics KROS
Chief Executive Officer
Holding Value $1.73M 165,000 shares
Last Trade
Jan 21, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$7.64M 165,000 shares
$46.30
$10.50
Eloxx Pharmaceuticals
Eloxx Pharmaceuticals ELOX
Director
Holding Value $30.2k 20,000 shares
Last Trade
May 19, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.18M 20,000 shares
$59.20
$1.51
Keros Therapeutics
Keros Therapeutics KROS
Chief Executive Officer
Holding Value $1.34M 127,200 shares
Last Trade
Jan 10, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$9.02M 127,200 shares
$70.93
$10.50
Eloxx Pharmaceuticals
Eloxx Pharmaceuticals ELOX
Director
Holding Value $30.2k 20,000 shares
Last Trade
May 20, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.71M 20,000 shares
$135.60
$1.51

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up